{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0615-8419",
      "generic_name": "Hydroxyzine Pamoate",
      "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs",
      "brand_name": "Hydroxyzine Pamoate",
      "active_ingredients": [
        {
          "name": "HYDROXYZINE PAMOATE",
          "strength": "25 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0615-8419-39",
          "description": "30 CAPSULE in 1 BLISTER PACK (0615-8419-39)",
          "marketing_start_date": "20220209",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "NCS HealthCare of KY, LLC dba Vangard Labs"
        ],
        "rxcui": [
          "995253",
          "995278"
        ],
        "spl_set_id": [
          "207d3478-ac7f-485c-b8ca-e9fcebbdcd89"
        ],
        "unii": [
          "M20215MUFR"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "b805a16f-99e8-4e22-902a-6eed48d51d4d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "19960715",
      "product_id": "0615-8419_b805a16f-99e8-4e22-902a-6eed48d51d4d",
      "application_number": "ANDA040156",
      "brand_name_base": "Hydroxyzine Pamoate",
      "pharm_class": [
        "Antihistamine [EPC]",
        "Histamine Receptor Antagonists [MoA]"
      ]
    }
  ]
}